(Q37988893)

26 August 2017

The epidemiology, pathogenesis and histopathology of fatty liver disease (English)

1 reference

26 August 2017

0 references

1 reference

0 references

Adam P Levene

1

1 reference

PubMed ID

22372457

26 August 2017

Robert D Goldin

series ordinal

2

1 reference

26 August 2017

28 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

61

1 reference

26 August 2017

2

1 reference

26 August 2017

141-152

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Epidemiology and natural history of NAFLD and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The critical dimension of ethnicity in liver cirrhosis mortality statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The evolving role of leptin and adiponectin in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Mechanisms of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Apoptosis: the nexus of liver injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Obesity and alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Alcohol, oxidative stress and free radical damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Alcohol and oxidative liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

ER stress: can the liver cope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Hepatocellular ballooning in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Physiological hepatic nuclear vacuolation--how long does it persist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Histopathology of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Clinical and pathological features of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04145.X

10.1111/J.1365-2559.2011.04145.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22372457